Let's see if NWBO and the authors provide the full details of the trial in their manuscript -- the original protocol, endpoints, comparator and SAP, tossing of the failed PFS primary endpoint, the post hoc data dredged recurrent GBM endpoint, etc.
Publishing misleading representations of the trial is deceptive.
Market Data 
Markets 
AI
